Demand accelerating in Aerospace, Defense & Government markets
Successfully completed an upsized IPO, raising
Revenue increased nearly 21%, with over 250 basis points of gross profit margin expansion driving adjusted EBITDA increase of 106%
Backlog increased by nearly 52% to record level of
First Quarter Fiscal Year 2026 Highlights
- Revenue increased 20.7% to approximately
$56.0 million compared to approximately$46.4 million in Q1 2025. - Revenue from our Critical Materials & Components (“CMC”) division increased approximately
$9.1 million compared to Q1 2025 primarily from growth within the Aerospace, Defense & Government (“ADG”) end market. - Gross profit margin improved 260 basis points to 21.2% of revenue compared to 18.6% of revenue Q1 2025.
- Net income (loss) for Q1 2026 was
$(0.3) million , or$(0.02) per share, compared to$1.2 million , or$0.06 per share, in Q1 2025. Adjusted net income (loss) for Q1 2026 was$4.7 million , or$0.24 per share, compared to$1.9 million , or$0.10 per share, in Q1 2025. - Adjusted EBITDA increased to approximately
$9.2 million , or 16.4% of revenue, compared to approximately$4.5 million , or 9.6% of revenue, in Q1 2025. - Open order backlog increased to approximately
$113.3 million , up from approximately$96.3 million at the end of Q4 2025 and approximately$74.7 million at the end of Q1 2025. - Recorded approximately
$3.7 million in income related to a change in fair value and mark to market of the Company’s strategic investment in tungsten mining company EQ Resources Limited.
Trailing Twelve Months Highlights
- Revenue increased 4.8% to approximately
$211.2 million compared to 2025 fiscal year results of approximately$201.6 million . - Gross profit margin improved 60 basis points to 20.9% of revenue compared to 20.3% for the 2025 fiscal year.
- Net income (loss) decreased to approximately
$4.0 million , or$0.20 per share, compared to$5.5 million , or$0.28 per share, for the 2025 fiscal year. Adjusted net income (loss) increased to approximately$16.2 million , or$0.81 per share, compared to$13.4 million , or$0.67 per share, for the 2025 fiscal year. - Adjusted EBITDA increased approximately
$5.2 million to$28.6 million , or 13.5% of revenue, compared to approximately$23.4 million , or 11.6% of revenue, for the 2025 fiscal year.
Management Commentary
“Today, we view the environment in which we operate as highly favorable and supported by strong demand for critical materials and engineered high-power systems, increasing defense spending, and ongoing supply chain realignment,” said Company CEO
“Our recent performance demonstrates the resilience and diversification of our operating model and our competitive strategic positioning within key growth markets, most notably ADG. We have built significant momentum, supported by our record backlog and newly fortified balance sheet, which we believe will allow us to make opportunistic investments to further support our long-term competitive positioning.”
Subsequent Events
Subsequent to the end of Q1 2026, we completed a successful upsized IPO of an aggregate of approximately 9.9 million shares of our common stock, including the full exercise by the underwriters of their overallotment option to purchase approximately 1.3 million additional shares, at a public offering price of
Conference Call
Toll-Free Number: 877-869-3847
International Number: +1 201-689-8261
Webcast: Register and Join
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact
The conference call will be broadcast simultaneously and available for webcast replay here.
About
Reorganization and Presentation of Financial Results
On
Non-GAAP Financial Measures
In evaluating its business, the Company uses or may use certain non-GAAP measures as supplemental measures to review and assess its operating and financial performance. These measures are commonly used in the manufacturing industry to provide stockholders and potential investors with additional information that excludes unusual or non-recurring items as well as non-cash items that are unrelated to or may not be indicative of the Company’s ongoing operating results. These measures may not be comparable to similar measures presented by other companies and should not be viewed as a substitute for measures reported under
Forward Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. These statements generally relate to future events or our future financial or operating performance and include statements regarding Elmet’s intended use of proceeds from the IPO, Elmet’s ability to: (i) effectively meet demand for its products, (ii) benefit from defense spending levels in
Company Contact
contact@theelmetgroup.com
Investor Contact
ELMT@gateway-grp.com
949-574-3860
-Financial tables to follow-
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (in thousands, except share data) | |||||||
2026 | 2025 | ||||||
| Assets | |||||||
| Current Assets: | |||||||
| Cash | $ | 1,825 | $ | 1,759 | |||
| Marketable securities | 838 | 202 | |||||
| Accounts receivable, net | 29,127 | 28,904 | |||||
| Government grant receivables | — | 1,690 | |||||
| Related party receivables | 178 | 426 | |||||
| Unbilled revenue | 3,610 | 2,621 | |||||
| Inventories, net | 75,032 | 69,697 | |||||
| Income tax receivable | 74 | — | |||||
| Derivative asset | 3,095 | — | |||||
| Prepaid expenses and other current assets | 6,462 | 4,774 | |||||
| Total current assets | 120,241 | 110,073 | |||||
| Property, plant and equipment, net | 44,185 | 42,342 | |||||
| Operating lease right-of-use assets | 10,448 | 10,586 | |||||
| Intangible assets, net | 6,870 | 7,184 | |||||
| 4,547 | 4,583 | ||||||
| Deferred tax assets, net | 84 | — | |||||
| Other assets | 872 | 878 | |||||
| Total assets | $ | 187,247 | $ | 175,646 | |||
| Liabilities and Stockholders’ Equity | |||||||
| Current Liabilities: | |||||||
| Accounts payable | $ | 17,679 | $ | 16,165 | |||
| Accrued expenses and other current liabilities | 13,765 | 13,659 | |||||
| Operating lease liabilities, current portion | 898 | 875 | |||||
| Current portion of long-term debt – related party | 2,396 | 2,319 | |||||
| Current portion of long-term debt | 6,229 | 7,755 | |||||
| Deferred government grants | 4,166 | 4,672 | |||||
| Deferred revenue | 23,494 | 14,853 | |||||
| Total current liabilities | 68,627 | 60,298 | |||||
| Operating lease liabilities, net of current portion | 10,022 | 10,247 | |||||
| Long-term debt, net of current portion | 26,768 | 28,455 | |||||
| Long-term debt, net of current portion – related party | 15,000 | 15,000 | |||||
| Deferred tax liabilities, net | 4,820 | — | |||||
| Other liabilities | 1,000 | 1,189 | |||||
| Total liabilities | 126,237 | 115,189 | |||||
| Commitments and Contingencies (Note 18) | |||||||
| Stockholders’ Equity: | |||||||
| Preferred Stock - | — | — | |||||
| Class A Common Stock – | 20 | 20 | |||||
| Class B Common Stock – | — | — | |||||
| Additional paid-in capital | 16,011 | 15,366 | |||||
| Retained earnings | 44,995 | 44,791 | |||||
| Accumulated other comprehensive (loss) income | (16 | ) | 280 | ||||
| Total stockholders’ equity | 61,010 | 60,457 | |||||
| Total liabilities and stockholders’ equity | $ | 187,247 | $ | 175,646 | |||
The accompanying notes are integral to the unaudited consolidated financial statements.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except share and per share data) | ||||||||
| Three Months Ended | ||||||||
2026 | 2025 | |||||||
| Revenue | $ | 56,007 | $ | 46,387 | ||||
| Cost of goods sold | 44,159 | 37,776 | ||||||
| Gross profit | 11,848 | 8,611 | ||||||
| Operating expenses: | ||||||||
| General and administrative | 7,068 | 3,259 | ||||||
| Research and development | 850 | 811 | ||||||
| Sales and marketing | 2,067 | 1,683 | ||||||
| Total operating expenses | 9,985 | 5,753 | ||||||
| Operating income | 1,863 | 2,858 | ||||||
| Other (income) expense, net: | ||||||||
| Interest expense | 613 | 510 | ||||||
| Interest expense – related party | 627 | 416 | ||||||
| Change in fair value of derivative asset | (3,095 | ) | — | |||||
| Other (income) expense, net | (654 | ) | 79 | |||||
| Total other (income) expense, net | (2,509 | ) | 1,005 | |||||
| Income from continuing operations before taxes | 4,372 | 1,853 | ||||||
| Income tax provision | 4,710 | — | ||||||
| (Loss) income from continuing operations | (338 | ) | 1,853 | |||||
| Loss from discontinued operations | — | (656 | ) | |||||
| Net (loss) income | $ | (338 | ) | $ | 1,197 | |||
| Net (loss) income per share: | ||||||||
| Basic | $ | (0.02 | ) | $ | 0.06 | |||
| Diluted | $ | (0.02 | ) | $ | 0.06 | |||
| Weighted average shares outstanding | ||||||||
| Basic | 20,123,187 | 20,123,187 | ||||||
| Diluted | 20,123,187 | 20,123,187 | ||||||
The accompanying notes are integral to the unaudited consolidated financial statements.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) | |||||||
| Three Months Ended | |||||||
2026 | 2025 | ||||||
| Cash flows from operating activities: | |||||||
| Net (loss) income | $ | (338) | $ | 1,197 | |||
| Loss from discontinued operations | — | (656) | |||||
| (Loss) income from continuing operations | (338) | 1,853 | |||||
| Adjustments to reconcile (loss) income from continuing operations to net cash provided by operating activities: | |||||||
| Deferred income taxes | 4,736 | — | |||||
| Change in fair value of derivative asset | (3,095) | — | |||||
| Depreciation and amortization | 1,923 | 1,604 | |||||
| Stock-based compensation | 645 | — | |||||
| Noncash operating lease expense | 138 | 217 | |||||
| Noncash interest expense | 6 | 7 | |||||
| Provision for excess and obsolete inventories | 36 | 395 | |||||
| Change in fair value of interest rate collars | (34) | (56) | |||||
| Unrealized gain on marketable securities | (636) | — | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (229) | 7,537 | |||||
| Unbilled revenue | (989) | (1,051) | |||||
| Inventories | (5,387) | (6,405) | |||||
| Related party receivables | 171 | (3) | |||||
| Income tax receivable | (74) | — | |||||
| Prepaid expenses and other current assets | (1,202) | (272) | |||||
| Other assets | (4) | 7 | |||||
| Accounts payable | 2,492 | 291 | |||||
| Accrued expenses and other current liabilities | 392 | (203) | |||||
| Operating lease liabilities | (202) | (188) | |||||
| Deferred revenue | 8,645 | 4,520 | |||||
| Other liabilities | (73) | (20) | |||||
| Net cash provided by operating activities from continuing operations | 6,921 | 8,233 | |||||
| Net cash used in operating activities from discontinued operations | — | (2,928) | |||||
| Net cash provided by operating activities | 6,921 | 5,305 | |||||
| Cash flows from investing activities: | |||||||
| Purchases of property, plant and equipment, net of grant proceeds (see Note 7 – Government Grants) | (2,337) | (2,733) | |||||
| Net cash used in investing activities from continuing operations | (2,337) | (2,733) | |||||
| Net cash used in investing activities from discontinued operations | — | (24) | |||||
| Net cash used in investing activities | (2,337) | (2,757) | |||||
| Cash flows from financing activities: | |||||||
| Payments of principal on revolving credit facility | (1,810) | (2,048) | |||||
| Proceeds from revolving credit facility | 164 | 400 | |||||
| Payments of principal on long-term debt | (1,074) | (2,966) | |||||
| Payments of principal on long-term debt – related party | (1,519) | — | |||||
| Cash distributions paid to stockholders | — | (1,789) | |||||
| Payments of deferred consideration | (73) | — | |||||
| Net payments of principal on revolving credit facility – related party | (150) | (32) | |||||
| Payments of principal on finance leases | (11) | (13) | |||||
| Net cash used in financing activities from continuing operations | (4,473) | (6,448) | |||||
| Net cash provided by financing activities from discontinued operations | — | 28 | |||||
| Net cash used in financing activities | (4,473) | (6,420) | |||||
| Effects of exchange rate changes on cash | (45) | 146 | |||||
| Net increase (decrease) in cash | $ | 66 | $ | (3,726) | |||
| Cash at beginning of period | 1,759 | 6,532 | |||||
| Cash at end of period | $ | 1,825 | $ | 2,806 | |||
| Reconciliation of cash at beginning of period: | |||||||
| Cash at beginning of period – continuing operations | $ | 1,759 | $ | 3,608 | |||
| Cash at beginning of period – discontinued operations | — | 2,924 | |||||
| Cash at beginning of period | $ | 1,759 | $ | 6,532 | |||
| Reconciliation of cash at end of period: | |||||||
| Cash at end of period – continuing operations | $ | 1,825 | $ | 2,806 | |||
| Cash at end of period – discontinued operations | — | — | |||||
| Cash at end of period | $ | 1,825 | $ | 2,806 | |||
| Supplemental non-cash investing and financing activities: | |||||||
| Purchases of property, plant and equipment included in accounts payable and accrued expenses | $ | 1,081 | $ | 52 | |||
| Deferred offering costs included in accounts payable and accrued expenses | $ | 1,346 | $ | — | |||
| Supplemental disclosure of cash flow information: | |||||||
| Cash paid for interest | $ | 1,085 | $ | 930 | |||
The accompanying notes are integral to the unaudited consolidated financial statements.
Non-GAAP Financial Measures:
The following tables display certain non-GAAP financial measures we believe are helpful in assessing our performance and interpreting our financial results. We believe these non-GAAP financial measures are important supplemental measures because they exclude unusual or non-recurring items as well as non-cash items that are unrelated to or may not be indicative of our ongoing operating results. Further, when read in conjunction with our GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as a tool to help make financial, operational and planning decisions. We may use non-GAAP financial metrics in certain management compensation plans, debt covenants, internal budgetary decision making and other resource allocation decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry by providing more comparable measures that are less affected by factors such as capital structure.
Adjusted EBITDA
Adjusted EBITDA is a non-GAAP measurement. We define Adjusted EBITDA as our net income plus interest expense, income taxes, depreciation and amortization, and, as applicable for each period, stock-based compensation expense and non-cash gains and losses on the sale of assets. Adjusted EBITDA also excludes certain non-recurring costs such as the costs associated with the IPO, certain acquisition and transaction costs, severance and restructuring costs, and other non-recurring costs.
ADJUSTED EBITDA FROM CONTINUING OPERATIONS (NON- GAAP, UNAUDITED) (in thousands) | |||||||||||||||
| Quarters Ended | |||||||||||||||
| Year ended 2025 | TTM 2026 | ||||||||||||||
| Revenue | $ | 46,387 | $ | 56,007 | $ | 201,636 | $ | 211,256 | |||||||
| Gross profit | 8,611 | 11,848 | 41,019 | 44,257 | |||||||||||
| Gross profit margin % | 18.6% | 21.2% | 20.3% | 20.9% | |||||||||||
| Operating expenses | 5,753 | 9,985 | 28,945 | 33,177 | |||||||||||
| Net income (loss) from continuing operations | 1,853 | (338) | 7,940 | 5,749 | |||||||||||
| Net income (loss) from continuing operations % | 4.0% | (0.6)% | 3.9% | 2.7% | |||||||||||
| Adjustments to income (loss) from continuing operations: | |||||||||||||||
| Income tax benefit | 4,710 | (45) | 4,665 | ||||||||||||
| Interest expense(1) | 926 | 1,240 | 4,410 | 4,724 | |||||||||||
| Depreciation and amortization | 1,604 | 1,923 | 6,048 | 6,367 | |||||||||||
| Acquisition and transaction costs(2) | 67 | 30 | 440 | 403 | |||||||||||
| Stock-based compensation(3) | 645 | 1,451 | 2,096 | ||||||||||||
| Corporate costs associated with the offering(4) | 10 | 798 | 2,580 | 3,368 | |||||||||||
| Other(5) | 166 | 1,013 | 1,179 | ||||||||||||
| Adjusted EBITDA (6) | $ | 4,460 | $ | 9,174 | $ | 23,387 | $ | 28,551 | |||||||
| Adjusted EBITDA Margin | 9.6% | 16.4% | 11.6% | 13.5% | |||||||||||
(1) Interest expense includes both third-party interest expense and related party interest expense.
(2) The adjustment for acquisition and transaction costs is to remove charges incurred in connection with any transaction, including mergers, acquisitions, refinancing, amendment or modification to indebtedness, and dispositions, in each case, regardless of whether consummated.
(3) Stock-based compensation includes expenses associated with restricted stock grants made in support of our initial public offering and the Reorganization.
(4) Corporate costs associated with the initial public offering include third-party expenses related to enhancing our accounting controls and procedures, incremental audit costs, recruitment of executive team and legal expenses.
(5) Others includes non-recurring costs associated with a utility failure at our CMC facility in
(6) Adjusted EBITDA excludes the financial impact of discontinued operations. On
Adjusted Net Income and Adjusted Net Income Per Share
Adjusted Net Income and Adjusted Net Income Per Share are non-GAAP measurements. We define adjusted net income as net income less stock-based compensation and one-time non-recurring costs such as tax impacts of the Reorganization, discontinued operations, the costs associated with the IPO, certain acquisition and transaction costs, severance and restructuring costs, and other non-recurring costs and the income tax effect of such adjustments, as applicable.
RECONCILIATION OF ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE (NON-GAAP, UNAUDITED) (in thousands) | |||||||||||||
| Quarters Ended | |||||||||||||
| Year ended 2025 | TTM 2026 | ||||||||||||
| Numerator: | |||||||||||||
| Net income (loss) | $ | 1,197 | $ | (338) | $ | 5,542 | $ | 4,007 | |||||
| Income (loss) from discontinued operations | 656 | 2,398 | 1,742 | ||||||||||
| One time tax expense associated with the Reorganization(1) | — | 3,791 | — | 3,791 | |||||||||
| Corporate costs associated with the IPO(2) | 10 | 798 | 2,580 | 3,368 | |||||||||
| Stock-based compensation(3) | — | 645 | 1,451 | 2,096 | |||||||||
| Acquisition and transaction costs(4) | 67 | — | 440 | 373 | |||||||||
| Other(5) | — | 196 | 1,013 | 1,209 | |||||||||
| Tax effect of adjustments(6) | — | (344) | — | (344) | |||||||||
| Adjusted net income | $ | 1,930 | $ | 4,748 | $ | 13,424 | $ | 16,242 | |||||
| Denominator: | |||||||||||||
| Weighted average shares outstanding – basic | 20,123 | 20,123 | 20,123 | 20,123 | |||||||||
| Weighted average shares outstanding – diluted(7) | 20,123 | 20,426 | 20,260 | 20,337 | |||||||||
| Adjusted net income per share: | |||||||||||||
| Basic | $ | 0.10 | $ | 0.24 | $ | 0.67 | $ | 0.81 | |||||
| Diluted(7) | $ | 0.10 | $ | 0.23 | $ | 0.66 | $ | 0.80 | |||||
| Unadjusted net income per share: | |||||||||||||
| Basic | $ | 0.06 | $ | (0.02) | $ | 0.28 | $ | 0.20 | |||||
| Diluted(7) | $ | 0.06 | $ | (0.02) | $ | 0.27 | $ | 0.20 | |||||
(1) Reflects the impact of the deferred tax adjustment of
(2) Corporate costs associated with the initial public offering include third-party expenses related to enhancing our accounting controls and procedures, incremental audit costs, recruitment of executive team and legal expenses.
(3) Stock-based compensation includes expenses associated with restricted stock grants made in support of our initial public offering and the Reorganization.
(4) The adjustment for acquisition and transaction costs is to remove charges incurred in connection with any transaction, including mergers, acquisitions, refinancing, amendment or modification to indebtedness, and dispositions, in each case, regardless of whether consummated.
(5) Other includes restructuring and severance costs associated with a reorganization at our CMC division and non-recurring costs associated with a utility failure at our CMC facility in
(6) The tax effect for the quarter ended
(7) The potential impact on weighted average common stock outstanding (diluted) related to our restricted stock was evaluated under the treasury stock method based on the weighted average unrecognized compensation costs for each period and the estimated fair value of our common stock for each period.
Source: 